Oncology Hematology Care, Inc. Oncology Hematology Care (2) — Cincinnati, Ohio

Oncology Hematology Care, Inc. Oncology Hematology Care (2) is a clinical research site located in Cincinnati, Ohio, United States 45242.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Oncology Hematology Care, Inc. Oncology Hematology Care (2) has participated in 1 clinical trials.

Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Hematology Care, Inc. Oncology Hematology Care (2)?

Oncology Hematology Care, Inc. Oncology Hematology Care (2) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Hematology Care, Inc. Oncology Hematology Care (2) conducted?

Oncology Hematology Care, Inc. Oncology Hematology Care (2) has 1 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib.

Is Oncology Hematology Care, Inc. Oncology Hematology Care (2) accredited by Crixeo Health?

Oncology Hematology Care, Inc. Oncology Hematology Care (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Hematology Care, Inc. Oncology Hematology Care (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.